The mean values of the non-invasive markers of liver fibrosis (AST/ALT ratio, APRI score, FIB-4 index, BARD score and NAFLD-fibrosis score) in the participants are enumerated in Table 3. This evidence concerns the gene GPT and metabolic dysfunction-associated steatotic liver disease.